Circadian rhythmicity, variability and correlation of interleukin-6 levels in plasma and cerebrospinal fluid of healthy men

Psychoneuroendocrinology

Volumn 44, Issue , 2014, Pages 71-82

  Agorastos, Agorastos ^a,b   Hauger, Richard L ^a,c,d   Barkauskas, Donald A ^e   Moeller Bertram, Tobias ^a,c,d   Clopton, Paul L ^c   Haji, Uzair ^c   Lohr, James B ^a,c,d   Geracioti, Thomas D ^f   Patel, Piyush M ^c,d   Chrousos, George P ^g   Baker, Dewleen G ^a,c,d  

^a VA CENTER OF EXCELLENCE FOR STRESS AND MENTAL HEALTH   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Blood brain barrier (BBB); Cerebrospinal fluid (CSF); Circadian; Cytokines; Immune; Inflammation; Interleukin 6 (IL 6); Neuroimmunology; Sleep; Stress

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; CYTOKINE RELEASE; HUMAN; HUMAN EXPERIMENT; INTERLEUKIN 6 BLOOD LEVEL; INTERLEUKIN 6 CEREBROSPINAL FLUID LEVEL; MALE; NORMAL HUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; REFERENCE VALUE; VOLUNTEER; BLOOD; CEREBROSPINAL FLUID; METABOLISM; PHYSIOLOGY; YOUNG ADULT;

ADULT; CIRCADIAN RHYTHM; HEALTHY VOLUNTEERS; HUMANS; INTERLEUKIN-6; MALE; YOUNG ADULT;

EID: 84899501675     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.02.020     Document Type: Article

References (128)

1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 1993, 54:1-78.
2. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., Ayala A.R., Licinio J., Gold H.K., Kling M.A., Chrousos G.P., Gold P.W. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 2005, 90:2522-2530.
3. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett. 1994, 179:53-56.
4. Bauer J., Hohagen F., Ebert T., Timmer J., Ganter U., Krieger S., Lis S., Postler E., Voderholzer U., Berger M. Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin. Investig. 1994, 72:315.
5. Berger A.M., Hertzog M., Geary C.R., Fischer P., Farr L. Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. J. Cancer Surviv. 2012.
6. Besedovsky H.O., del Rey A. Central and peripheral cytokines mediate immune-brain connectivity. Neurochem. Res. 2011, 36:1-6.
7. Bethin K.E., Vogt S.K., Muglia L.J. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9317-9322.
8. Biddle C. The neurobiology of the human febrile response. AANA J. 2006, 74:145-150.
9. Bluthe R.M., Michaud B., Poli V., Dantzer R. Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol. Behav. 2000, 70:367-373.
10. Brandner S., Thaler C., Lewczuk P., Lelental N., Buchfelder M., Kleindienst A. Neuroprotein dynamics in the cerebrospinal fluid: intraindividual concomitant ventricular and lumbar measurements. Eur. Neurol. 2013, 70:189-194.
11. Browning L.M., Krebs J.D., Jebb S.A. Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic disease. Metabolism 2004, 53:899-903.
12. Bryant P.A., Trinder J., Curtis N. Sick and tired: does sleep have a vital role in the immune system?. Nat. Rev. Immunol. 2004, 4:457-467.
13. Burgos I., Richter L., Klein T., Fiebich B., Feige B., Lieb K., Voderholzer U., Riemann D. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav. Immun. 2006, 20:246-253.
14. Carey A.L., Bruce C.R., Sacchetti M., Anderson M.J., Olsen D.B., Saltin B., Hawley J.A., Febbraio M.A. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 2004, 47:1029-1037.
15. Castanon-Cervantes O., Wu M., Ehlen J.C., Paul K., Gamble K.L., Johnson R.L., Besing R.C., Menaker M., Gewirtz A.T., Davidson A.J. Dysregulation of inflammatory responses by chronic circadian disruption. J. Immunol. 2010, 185:5796-5805.
16. Castell J.V., Gomez-Lechon M.J., David M., Andus T., Geiger T., Trullenque R., Fabra R., Heinrich P.C. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989, 242:237-239.
17. Chourbaji S., Urani A., Inta I., Sanchis-Segura C., Brandwein C., Zink M., Schwaninger M., Gass P. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol. Dis. 2006, 23:587-594.
18. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 1995, 332:1351-1362.
19. Clapp-Lilly K.L., Smith M.A., Perry G., Duffy L.K. Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices. Chem. Biol. Interact. 2001, 134:101-107.
20. Conti B., Tabarean I., Andrei C., Bartfai T. Cytokines and fever. Front. Biosci. 2004, 9:1433-1449.
21. Coogan A.N., Wyse C.A. Neuroimmunology of the circadian clock. Brain Res. 2008, 1232:104-112.
22. Crofford L.J., Kalogeras K.T., Mastorakos G., Magiakou M.A., Wells J., Kanik K.S., Gold P.W., Chrousos G.P., Wilder R.L. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab. 1997, 82:1279-1283.
23. Cutolo M., Sulli A., Pizzorni C., Secchi M.E., Soldano S., Seriolo B., Straub R.H., Otsa K., Maestroni G.J. Circadian rhythms: glucocorticoids and arthritis. Ann. N. Y. Acad. Sci. 2006, 1069:289-299.
24. Cutolo M., Villaggio B., Otsa K., Aakre O., Sulli A., Seriolo B. Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. Autoimmun. Rev. 2005, 4:497-502.
25. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:953-966.
26. De Simoni M.G., Del Bo R., De Luigi A., Simard S., Forloni G. Central endotoxin induces different patterns of interleukin (IL)-1 beta and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery. Endocrinology 1995, 136:897-902.
27. DeRijk R.H., Boelen A., Tilders F.J., Berkenbosch F. Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 1994, 19:155-163.
28. Dimitrov S., Lange T., Benedict C., Nowell M.A., Jones S.A., Scheller J., Rose-John S., Born J. Sleep enhances IL-6 trans-signaling in humans. FASEB J. 2006, 20:2174-2176.
29. Dugue B., Leppanen E. Short-term variability in the concentration of serum interleukin-6 and its soluble receptor in subjectively healthy persons. Clin. Chem. Lab. Med. 1998, 36:323-325.
30. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem. Int. 2008, 52:40-51.
31. Elenkov I.J., Iezzoni D.G., Daly A., Harris A.G., Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005, 12:255-269.
32. Engler H., Doenlen R., Riether C., Engler A., Besedovsky H.O., Del Rey A., Pacheco-Lopez G., Schedlowski M. Chemical destruction of brain noradrenergic neurons affects splenic cytokine production. J. Neuroimmunol. 2010, 219:75-80.
33. Erren T.C., Reiter R.J. Defining chronodisruption. J. Pineal Res. 2009, 46:245-247.
34. Fantidis P., Perez De Prada T., Fernandez-Ortiz A., Carcia-Touchard A., Alfonso F., Sabate M., Hernandez R., Escaned J., Bauelos C., Macaya C. Morning cortisol production in coronary heart disease patients. Eur. J. Clin. Invest. 2002, 32:304-308.
35. Fee D., Grzybicki D., Dobbs M., Ihyer S., Clotfelter J., Macvilay S., Hart M.N., Sandor M., Fabry Z. Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. Cytokine 2000, 12:655-665.
36. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version 2002, Biometrics Research, New York State Psychiatric Institute, New York. Non-patient Edition (SCID-I/NP).
37. Garcia-Maurino S., Pozo D., Calvo J.R., Guerrero J.M. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J. Pineal Res. 2000, 29:129-137.
38. Giannoulia-Karantana A., Vlachou A., Polychronopoulou S., Papassotiriou I., Chrousos G.P. Melatonin and immunomodulation: connections and potential clinical applications. Neuroimmunomodulation 2006, 13:133-144.
39. Girotti M., Donegan J.J., Morilak D.A. Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology 2012.
40. Gruol D.L., Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 1997, 15:307-339.
41. Gudewill S., Pollmacher T., Vedder H., Schreiber W., Fassbender K., Holsboer F. Nocturnal plasma levels of cytokines in healthy men. Eur. Arch. Psychiatry Clin. Neurosci. 1992, 242:53-56.
42. Guerrero J.M., Pozo D., Garcia-Maurino S., Carrillo A., Osuna C., Molinero P., Calvo J.R. Nuclear receptors are involved in the enhanced IL-6 production by melatonin in U937 cells. Biol. Signals Recept. 2000, 9:197-202.
43. Haack M., Kraus T., Schuld A., Dalal M., Koethe D., Pollmacher T. Diurnal variations of interleukin-6 plasma levels are confounded by blood drawing procedures. Psychoneuroendocrinology 2002, 27:921-931.
44. Haack M., Pollmacher T., Mullington J.M. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain. Behav. Immun. 2004, 18:361-367.
45. Haack M., Reichenberg A., Kraus T., Schuld A., Yirmiya R., Pollmacher T. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men. Cytokine 2000, 12:694-698.
46. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
47. Hanke M.L., Powell N.D., Stiner L.M., Bailey M.T., Sheridan J.F. Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress. Brain. Behav. Immun. 2012, 26:1150-1159.
48. Hansel A., Hong S., Camara R.J., von Kanel R. Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci. Biobehav. Rev. 2010, 35:115-121.
49. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
50. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990, 265:621-636.
51. Helwig B.G., Craig R.A., Fels R.J., Blecha F., Kenney M.J. Central nervous system administration of interleukin-6 produces splenic sympathoexcitation. Auton. Neurosci. 2008, 141:104-111.
52. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986, 324:73-76.
53. Hopkins S.J. Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration. Acta Biomed. 2007, 78(Suppl. 1):231-247.
54. Imeri L., Opp M.R. How (and why) the immune system makes us sleep. Nat. Rev. Neurosci. 2009, 10:199-210.
55. Innominato P.F., Levi F.A., Bjarnason G.A. Chronotherapy and the molecular clock: clinical implications in oncology. Adv. Drug. Deliv. Rev. 2010, 62:979-1001.
56. Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain Behav. Immun. 2002, 16:503-512.
57. Iwata K., Aizawa K., Sakai S., Jingami S., Fukunaga E., Yoshida M., Hamada A., Saito H. The relationship between treatment time of gemcitabine and development of hematologic toxicity in cancer patients. Biol. Pharm. Bull. 2011, 34:1765-1768.
58. Izawa S., Miki K., Liu X., Ogawa N. The diurnal patterns of salivary interleukin-6 and C-reactive protein in healthy young adults. Brain Behav. Immun. 2013, 27:38-41.
59. Izawa S., Miki K., Liu X.X., Ogawa N. The diurnal patterns of salivary interleukin-6 and C-reactive protein in healthy young adults. Brain Behav. Immun. 2013, 27:38-41.
60. Judd A.M. Cytokine expression in the rat adrenal cortex. Horm. Metab. Res. 1998, 30:404-410.
61. Juttler E., Tarabin V., Schwaninger M. Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity. Neuroscientist 2002, 8:268-275.
62. Kanabrocki E.L., Sothern R.B., Messmore H.L., Roitman-Johnson B., McCormick J.B., Dawson S., Bremner F.W., Third J.L., Nemchausky B.A., Shirazi P., Scheving L.E. Circadian interrelationships among levels of plasma fibrinogen, blood platelets, and serum interleukin-6. Clin. Appl. Thromb. Hemost. 1999, 5:37-42.
63. Keller E.T., Wanagat J., Ershler W.B. Molecular and cellular biology of interleukin-6 and its receptor. Front. Biosci. 1996, 1:d340-d357.
64. Keller M., Mazuch J., Abraham U., Eom G.D., Herzog E.D., Volk H.D., Kramer A., Maier B. A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21407-21412.
65. Lau W.W., Ng J.K., Lee M.M., Chan A.S., Wong Y.H. Interleukin-6 autocrine signaling mediates melatonin MT(1/2) receptor-induced STAT3 Tyr(705) phosphorylation. J. Pineal Res. 2011.
66. Lemmer B., Schwulera U., Thrun A., Lissner R. Circadian rhythm of soluble interleukin-2 receptor in healthy individuals. Eur. Cytokine Netw. 1992, 3:335-336.
67. Levi F., Focan C., Karaboue A., de la Valette V., Focan-Henrard D., Baron B., Kreutz F., Giacchetti S. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Adv. Drug Deliv. Rev. 2007, 59:1015-1035.
68. Lindqvist D., Janelidze S., Hagell P., Erhardt S., Samuelsson M., Minthon L., Hansson O., Bjorkqvist M., Traskman-Bendz L., Brundin L. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol. Psychiatry 2009, 66:287-292.
69. Lissoni P., Rovelli F., Brivio F., Brivio O., Fumagalli L. Circadian secretions of IL-2, IL-12 IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Nat. Immun. 1998, 16:1-5.
70. Macchi M.M., Bruce J.N. Human pineal physiology and functional significance of melatonin. Front. Neuroendocrinol. 2004, 25:177-195.
71. Maier B., Laurer H.L., Rose S., Buurman W.A., Marzi I. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J. Neurotrauma 2005, 22:822-835.
72. Manolagas S.C., Jilka R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 1995, 332:305-311.
73. Marshall L., Born J. Brain-immune interactions in sleep. Int. Rev. Neurobiol. 2002, 52:93-131.
74. Marz P., Otten U., Rose-John S. Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur. J. Neurosci. 1999, 11:2995-3004.
75. Mastorakos G., Chrousos G.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 1993, 77:1690-1694.
76. Mihara M., Hashizume M., Yoshida H., Suzuki M., Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.) 2012, 122:143-159.
77. Mohamed-Ali V., Flower L., Sethi J., Hotamisligil G., Gray R., Humphries S.E., York D.A., Pinkney J. beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 2001, 86:5864-5869.
78. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Klein S., Coppack S.W. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 1997, 82:4196-4200.
79. Monje F.J., Cabatic M., Divisch I., Kim E.J., Herkner K.R., Binder B.R., Pollak D.D. Constant darkness induces IL-6-dependent depression-like behavior through the NF-kappaB signaling pathway. J. Neurosci. 2011, 31:9075-9083.
80. Motzkus D., Albrecht U., Maronde E. The human PER1 gene is inducible by interleukin-6. J. Mol. Neurosci. 2002, 18:105-109.
81. Nader N., Chrousos G.P., Kino T. Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol. Metab. 2010, 21:277-286.
82. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K., Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem. Biophys. Res. Commun. 1988, 155:1459-1463.
83. Nishimoto N. Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin. Pharmacol. Ther. 2010, 87:483-487.
84. Otten U., Scully J.L., Ehrhard P.B., Gadient R.A. Neurotrophins: signals between the nervous and immune systems. Prog. Brain Res. 1994, 103:293-305.
85. Papanicolaou D.A., Petrides J.S., Tsigos C., Bina S., Kalogeras K.T., Wilder R., Gold P.W., Deuster P.A., Chrousos G.P. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am. J. Physiol. 1996, 271:E601-E605.
86. Papanicolaou D.A., Tsigos C., Oldfield E.H., Chrousos G.P. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency?. J. Clin. Endocrinol. Metab. 1996, 81:2303-2306.
87. Papanicolaou D.A., Vgontzas A.N. Interleukin-6: the endocrine cytokine. J. Clin. Endocrinol. Metab. 2000, 85:1331-1333.
88. Perry M.G., Kirwan J.R., Jessop D.S., Hunt L.P. Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann. Rheum. Dis. 2009, 68:63-68.
89. Redwine L., Hauger R.L., Gillin J.C., Irwin M. Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J. Clin. Endocrinol. Metab. 2000, 85:3597-3603.
90. Reiber H., Otto M., Trendelenburg C., Wormek A. Reporting cerebrospinal fluid data: knowledge base and interpretation software. Clin. Chem. Lab. Med. 2001, 39:324-332.
91. Reyes T.M., Coe C.L. Interleukin-1 beta differentially affects interleukin-6 and soluble interleukin-6 receptor in the blood and central nervous system of the monkey. J. Neuroimmunol. 1996, 66:135-141.
92. Reyes T.M., Coe C.L. Resistance of central nervous system interleukin-6 to glucocorticoid inhibition in monkeys. Am. J. Physiol. 1998, 275:R612-R618.
93. Rohleder N., Aringer M., Boentert M. Role of interleukin-6 in stress, sleep, and fatigue. Ann. N. Y. Acad. Sci. 2012, 1261:88-96.
94. Rose-John S., Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J. 1994, 300(Pt 2):281-290.
95. Rose-John S., Waetzig G.H., Scheller J., Grotzinger J., Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin. Ther. Targets. 2007, 11:613-624.
96. Sadeh A., Alster J., Urbach D., Lavie P.A. Actigraphically based automatic bedtime sleep-wake scoring: validity and clinical applications. Ambul. Monit. 1989, 2:209-216.
97. Salas M.A., Evans S.W., Levell M.J., Whicher J.T. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin. Exp. Immunol. 1990, 79:470-473.
98. Sanceau J., Kaisho T., Hirano T., Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J. Biol. Chem. 1995, 270:27920-27931.
99. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011, 1813:878-888.
100. Seiler W., Muller H., Hiemke C. Diurnal variations of plasma interleukin-6 in man: methodological implications of continuous use of indwelling cannulae. Ann. N. Y. Acad. Sci. 1995, 762:468-470.
101. Sewlall S., Pillay V., Danckwerts M.P., Choonara Y.E., Ndesendo V.M., du Toit L.C. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr. Drug. Deliv. 2010, 7:370-388.
102. Sondergaard S.R., Ostrowski K., Ullum H., Pedersen B.K. Changes in plasma concentrations of interleukin-6 and interleukin-1 receptor antagonists in response to adrenaline infusion in humans. Eur. J. Appl. Physiol. 2000, 83:95-98.
103. Sothern R.B., Roitman-Johnson B., Kanabrocki E.L., Yager J.G., Fuerstenberg R.K., Weatherbee J.A., Young M.R., Nemchausky B.M., Scheving L.E. Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In Vivo 1995, 9:331-339.
104. Sothern R.B., Roitman-Johnson B., Kanabrocki E.L., Yager J.G., Roodell M.M., Weatherbee J.A., Young M.R., Nenchausky B.M., Scheving L.E. Circadian characteristics of circulating interleukin-6 in men. J. Allergy Clin. Immunol. 1995, 95:1029-1035.
105. Spies C.M., Cutolo M., Straub R.H., Burmester G.R., Buttgereit F. More night than day-circadian rhythms in polymyalgia rheumatica and ankylosing spondylitis. J. Rheumatol. 2010, 37:894-899.
106. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., Gerlo S. Interleukin-6, a mental cytokine. Brain Res. Rev. 2011, 67:157-183.
107. Srinivasan V., Spence D.W., Pandi-Perumal S.R., Trakht I., Cardinali D.P. Therapeutic actions of melatonin in cancer: possible mechanisms. Integr. Cancer Ther. 2008, 7:189-203.
108. Srinivasan V., Spence D.W., Trakht I., Pandi-Perumal S.R., Cardinali D.P., Maestroni G.J. Immunomodulation by melatonin: its significance for seasonally occurring diseases. Neuroimmunomodulation 2008, 15:93-101.
109. Steensberg A., Dalsgaard M.K., Secher N.H., Pedersen B.K. Cerebrospinal fluid IL-6 HSP72, and TNF-alpha in exercising humans. Brain Behav. Immun. 2006, 20:585-589.
110. Stenlof K., Wernstedt I., Fjallman T., Wallenius V., Wallenius K., Jansson J.O. Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J. Clin. Endocrinol. Metab. 2003, 88:4379-4383.
111. Steptoe A., Hamer M., Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 2007, 21:901-912.
112. Sternberg E.M. Neuroendocrine regulation of autoimmune/inflammatory disease. J. Endocrinol. 2001, 169:429-435.
113. Stouthard J.M., Romijn J.A., Van der Poll T., Endert E., Klein S., Bakker P.J., Veenhof C.H., Sauerwein H.P. Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 1995, 268:E813-E819.
114. Streit W.J., Hurley S.D., McGraw T.S., Semple-Rowland S.L. Comparative evaluation of cytokine profiles and reactive gliosis supports a critical role for interleukin-6 in neuron-glia signaling during regeneration. J. Neurosci. Res. 2000, 61:10-20.
115. Swartz K.R., Liu F., Sewell D., Schochet T., Campbell I., Sandor M., Fabry Z. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 2001, 896:86-95.
116. Tilgner J., Volk B., Kaltschmidt C. Continuous interleukin-6 application in vivo via macroencapsulation of interleukin-6-expressing COS-7 cells induces massive gliosis. Glia 2001, 35:234-245.
117. Tominaga T., Fukata J., Naito Y., Usui T., Murakami N., Fukushima M., Nakai Y., Hirai Y., Imura H. Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology 1991, 128:526-531.
118. van Gool J., van Vugt H., Helle M., Aarden L.A. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin. Immunol. Immunopathol. 1990, 57:200-210.
119. Van Wagoner N.J., Oh J.W., Repovic P., Benveniste E.N. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J. Neurosci. 1999, 19:5236-5244.
120. Vankelecom H., Carmeliet P., Van Damme J., Billiau A., Denef C. Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 1989, 49:102-106.
121. Vgontzas A.N., Bixler E.O., Lin H.M., Prolo P., Trakada G., Chrousos G.P. IL-6 and its circadian secretion in humans. Neuroimmunomodulation 2005, 12:131-140.
122. Vgontzas A.N., Chrousos G.P. Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. Endocrinol. Metab. Clin. North Am. 2002, 31:15-36.
123. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Lotsikas A., Zachman K., Kales A., Prolo P., Wong M.L., Licinio J., Gold P.W., Hermida R.C., Mastorakos G., Chrousos G.P. Circadian interleukin-6 secretion and quantity and depth of sleep. J. Clin. Endocrinol. Metab. 1999, 84:2603-2607.
124. Vgontzas A.N., Zoumakis M., Bixler E.O., Lin H.M., Prolo P., Vela-Bueno A., Kales A., Chrousos G.P. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J. Clin. Endocrinol. Metab. 2003, 88:2087-2095.
125. Vgontzas A.N., Zoumakis M., Papanicolaou D.A., Bixler E.O., Prolo P., Lin H.M., Vela-Bueno A., Kales A., Chrousos G.P. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism 2002, 51:887-892.
126. Vicennati V., Vottero A., Friedman C., Papanicolaou D.A. Hormonal regulation of interleukin-6 production in human adipocytes. Int. J. Obes. Relat. Metab. Disord. 2002, 26:905-911.
127. Wilder R.L. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 1995, 13:307-338.
128. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993, 133:2523-2530.